Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cardiol Therapeutics Inc
T.CRDL
Alternate Symbol(s):
CRDL
Healthcare
Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is...
recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CRDL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(3)
•••
SlangEditor00
X
View Profile
View Bullboard History
Comment by
SlangEditor00
on Nov 10, 2020 12:22pm
RE:RE:RE:RE:RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
Thank goodness givemealife grammer police is on site. What would we do without all his wild delerious assumptions?! ANSWER THE QUESTION YOU NON STOP TYPING WASTE OF SPACE! 1. Where can I buy Biovec
...more
(2)
•••
GiveMeMoney
X
View Profile
View Bullboard History
Comment by
GiveMeMoney
on Nov 10, 2020 10:19am
RE:RE:RE:RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
The long-term viability of this thing is in question: Biovetra could come in at any time with someone's (Apotex?) generic front-end and knock its' cortcul off the shelf at lower price points.
...more
GameSquare Holdings Reports Record 2024 Third Quarter Results
posted Nov 15, 2024 9:00am by
GameSquare Holdings Inc.
-
|
Justin Kenna, CEO of GameSquare, stated, "GameSquare delivered strong third quarter financial results that were in line with our pre-announcement, and reflect the strategies underway to drive organic sales growth, complete the integration of our recent acquisitions, and build a profitable organization. On a sequential basis, I am encouraged by the ...read more
(3)
•••
SlangEditor00
X
View Profile
View Bullboard History
Comment by
SlangEditor00
on Nov 09, 2020 9:55pm
RE:RE:RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
Givememoney how about give me a break. It is a pure product - as in don't have to take as much - as in 100% consistent - as in can be perscribed to children. I could go on of course but everyone
...more
(3)
•••
SlangEditor00
X
View Profile
View Bullboard History
Comment by
SlangEditor00
on Nov 09, 2020 9:43pm
RE:Kraft dinner...easier to swallow than CRDL!
Easy now. Take medication please.
(4)
•••
cascao1
X
View Profile
View Bullboard History
Comment by
cascao1
on Nov 09, 2020 10:27am
RE:RE:FDA Approval for Investigational New Drug (IND) Application
Thanks
(2)
•••
GiveMeMoney
X
View Profile
View Bullboard History
Comment by
GiveMeMoney
on Nov 08, 2020 10:32am
RE:RE:FDA Approval for Investigational New Drug (IND) Application
Is that why the stock price bounces up and down between $2.5-$3? I didn't know that the previous could be baked into a loser.
(79)
•••
Youhillman
X
View Profile
View Bullboard History
Comment by
Youhillman
on Nov 08, 2020 10:04am
RE:FDA Approval for Investigational New Drug (IND) Application
cascao1..... here is an update regarding your query on next steps & approvals......... Cardiol’s Phase 1 clinical study of CardiolRx is on schedule to be completed during Q4, 2020, and is
...more
(2)
•••
GiveMeMoney
X
View Profile
View Bullboard History
Post by
GiveMeMoney
on Nov 08, 2020 8:47am
Kraft dinner...easier to swallow than CRDL!
How poetic: CRDL is taken orally and probably tastes like s$%t, part of its charm. After all, "it's good medicine: it costs $399/botltle FFS!!" But Kraft dinner eh!!? Now this is just
...more
(6)
•••
NorthBuddy
X
View Profile
View Bullboard History
Comment by
NorthBuddy
on Nov 08, 2020 7:08am
RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
But, but,.. I like Kraft dinner.
(2)
•••
GiveMeMoney
X
View Profile
View Bullboard History
Comment by
GiveMeMoney
on Nov 07, 2020 6:07pm
RE:RE:FDA Approval for Investigational New Drug (IND) Application
Another few for sure.
(2)
•••
GiveMeMoney
X
View Profile
View Bullboard History
Comment by
GiveMeMoney
on Nov 07, 2020 6:05pm
RE:RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
This is not the end-all-and-be-all of co's nor stocks and anyone who's actually reading and, actually, studying how they are trying to add hype to their SP will ask themselves WHY? Brokers
...more
(2)
•••
NewFanCBD
X
View Profile
View Bullboard History
Comment by
NewFanCBD
on Nov 07, 2020 5:41am
RE:RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
Well your right about $22 I'll give you that. Tip - Put a period after dinner; capital I on If. GO CARDIOL!! TL
(15)
•••
Mapleleaf57
X
View Profile
View Bullboard History
Comment by
Mapleleaf57
on Nov 06, 2020 6:29pm
RE:RE:RE:FDA Approval for Investigational New Drug (IND) Application
Facts are Facts,, do you see the price right now? when it goes to $22 I will come back and say your correct ,, great company,, by the way I wish my mom could make me Kraft dinner, if you dont
...more
(2)
•••
NewFanCBD
X
View Profile
View Bullboard History
Comment by
NewFanCBD
on Nov 06, 2020 3:58pm
RE:RE:FDA Approval for Investigational New Drug (IND) Application
Hahaha. Hilarious. Crazy shorter. Get your facts straight! While youre at it, go have a shower, finish off the Kraft dinner your mom made at lunch, and get working on your homework. Not the brightest
...more
(15)
•••
Mapleleaf57
X
View Profile
View Bullboard History
Comment by
Mapleleaf57
on Nov 06, 2020 12:54pm
RE:FDA Approval for Investigational New Drug (IND) Application
Newfan will let you know, he works to promotes CRDL... I wonder what other company he promotes on B.B..
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
New Gold and Copper Hotspot Identified – What’s Next for This Serbian Project?
Explained: The Psychology of Options Trading with Practical Tips
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Major Funding Secured! Company Closes First Round of Private Placement
This $10M Deal Could Reshape the Future of Global Creator Platforms
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Gold, growth and sustainability in focus for this resource company